PhRMA to Present Clinical Trial Exceptional Service Award
WASHINGTON,March 9, 2007 — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin announced the following Capitol Hill press conference:
WHAT: PhRMA will hold a press conference to present the first-ever
Clinical Trial Exceptional Service Award
WHO: Billy Tauzin, President and CEO, PhRMA
Karen Katen, Vice Chairman, Pfizer Inc
Bob Franks, President, Healthcare Institute of New Jersey
Donald H. Batts, M.D., FACP, Professor of Medicine, College of Human Medicine-
Kalamazoo Campus, Michigan State University
Sharon Nachman, M.D., Professor of Pediatrics, Department of Pediatrics-
State University of New York at Stony Brook
Maryam Imam, Clinical Trial Participant for Zyvox™
WHEN: Wednesday, March 14, 2007
5:00 PM
WHERE: 340 Rayburn House Office Building
On March 14, PhRMA will recognize clinical researchers who have made incredible contributions to the research and development of a revolutionary medicine that helps patients live longer, healthier lives. PhRMA will announce and present the first-ever Clinical Trial Exceptional Service Award to the researchers who have advanced a scientific breakthrough that has helped improve the lives of patients worldwide.
This year’s Clinical Trial Exceptional Service Award will be presented to two physicians who were instrumental in the clinical trial process for Pfizer’s prescription drug Zyvox™. This award also will be given to an 11-year-old patient who participated in the clinical trials that were critical to the development of this life-saving treatment.
Zyvox™ is used to help treat infections caused by life-threatening bacteria as well as pneumonia. More than one million patients worldwide have been helped by Zyvox™ since it was approved in 2000 by the Food and Drug Administration.
In addition, the annual PhRMA Discoverers Award bestowed to the pharmaceutical scientists who discovered Zyvox™ also will be present at this news conference. The Discoverers Award researchers are Michael Barbachyn, Ph.D., Pfizer; Steven Brickner, Ph.D., Pfizer; and Douglas Hutchinson, Ph.D., formerly with Pfizer and now with Abbott. They will be honored at a dinner the following evening.
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $43 billion in 2006 in discovering and developing new medicines. Industry-wide research and investment reached a record $55.2 billion in 2006.
###
PhRMA Internet Address: http://www.phrma.org/">http://www.phrma.org
For information on how innovative medicines save lives, visit: http://www.innovation.org/">http://www.innovation.org
For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org/">http://www.pparx.org
For information on the danger of imported drugs, visit: http://www.buysafedrugs.info/">http://www.buysafedrugs.info
Contact: Jennifer Page
(202) 835-3460
Pharma Industry News Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
